Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-18T12:21:49.976Z Has data issue: false hasContentIssue false

3 - Mechanisms of Bile Formation and Cholestasis

from SECTION I - PATHOPHYSIOLOGY OF PEDIATRIC LIVER DISEASE

Published online by Cambridge University Press:  18 December 2009

Saul J. Karpen M.D., Ph.D.
Affiliation:
Associate Professor of Pediatrics and Molecular and Cellular Biology, Faculty, Transitional Biology and Molecular Medicine Program, Department of Pediatrics, Baylor College of Medicine, Houston, Texas; Director, Texas Children's Liver Center, Department of Pediatric Gastroenterology, Hepatology, and Nutrition, Texas Children's Hospital, Houston, Texas
Frederick J. Suchy
Affiliation:
Mount Sinai School of Medicine, New York
Ronald J. Sokol
Affiliation:
University of Colorado, Denver
William F. Balistreri
Affiliation:
University of Cincinnati
Get access

Summary

With the recent findings of genetic causes of cholestasis (see Chapter 14), many of the previously ascribed “indeterminate” forms of cholestasis have been assigned molecular forms of causality because of specific impairments in critical genes involved in the formation of bile. In a similar vein, exploration of the effects of various endogenous and exogenous factors on the expression and function of these same essential bile formation genes has led to a greater molecular understanding of acquired forms of cholestasis. Thus, within the past 5–10 years, it has become possible to tease apart not only the means by which the liver is damaged by rare single-gene defects in critical hepatobiliary genes, but also how these gene products are engaged in the response and adaptation to cholestasis, and intriguingly, why these processes may not be fully adequate to protect the liver. In particular, see Chapter 14 and recent references [1–6] for our increasing knowledge of the expression, structure, and regulation of these genes and gene products in the underlying processes that lead to cholestasis. Among the more relevant findings has been that the processes of bile formation, cholestasis, and adaptation are inherently intertwined with structural, developmental, biochemical, intercellular communication, subcellular organization, cell signaling pathways, and physiologic components of the liver and liver function. In this chapter, attention focuses upon the basic mechanisms of bile formation as well as the genetic and acquired pathways that lead to cholestasis.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Wagner, M, Trauner, M. Transcriptional regulation of hepatobiliary transport systems in health and disease: implications for a rationale approach to the treatment of intrahepatic cholestasis. Ann Hepatol 2005;4:77–99.Google ScholarPubMed
Trauner, M, Boyer, J L. Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 2003;83:633–71.CrossRefGoogle ScholarPubMed
Balistreri, W F, Bezerra, J A, Jansen, P. Intrahepatic cholestasis: summary of an American Association for the Study of Liver Diseases single-topic conference. Hepatology 2005;42:222–35.CrossRefGoogle Scholar
Karpen, S J. Nuclear receptor regulation of hepatic function. J Hepatol 2002;36:832–50.CrossRefGoogle ScholarPubMed
Elferink, Oude R P, Paulusma, C C, Groen, A K. Hepatocanalicular transport defects: pathophysiologic mechanisms of rare diseases. Gastroenterology 2006;130:908–25.CrossRefGoogle Scholar
Eloranta, J J, Meier, P J, Kullak-Ublick, G A. Coordinate transcriptional regulation of transport and metabolism. Methods Enzymol 2005;400:511–30.CrossRefGoogle ScholarPubMed
Hofmann, A F. The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med 1999;159:2647–58.CrossRefGoogle ScholarPubMed
Feranchak, A P, Sokol, R J. Cholangiocyte biology and cystic fibrosis liver disease. Semin Liver Dis 2001;21:471–88.CrossRefGoogle ScholarPubMed
Scharschmidt, B F, Lake, J R. Hepatocellular bile acid transport and ursodeoxycholic acid hypercholeresis. Dig Dis Sci 1989;34(Suppl 12):5S–15S.CrossRefGoogle Scholar
Kullak-Ublick, G A, Stieger, B, Meier, P J. Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 2004;126:322–42.CrossRefGoogle ScholarPubMed
Miettinen, T A, Klett, E L, Gylling, H. Liver transplantation in a patient with sitosterolemia and cirrhosis. Gastroenterology 2006;130:542–7.CrossRefGoogle Scholar
Salen, G, Patel, S, Batta, A K. Sitosterolemia. Cardiovasc Drug Rev 2002;20:255–70.CrossRefGoogle ScholarPubMed
Keitel, V, Nies, A T, Brom, M. A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2). Am J Physiol Gastrointest Liver Physiol 2003;284:G165–74.CrossRefGoogle Scholar
Nathanson, M H, Boyer, J L. Mechanisms and regulation of bile secretion. Hepatology 1991;14:551–66.CrossRefGoogle ScholarPubMed
Hofmann, A F. The enterohepatic circulation of bile acids in man. Clin Gastroenterol 1977;6:3–24.Google ScholarPubMed
Northfield, T C, Hofmann, A F. Biliary lipid output during three meals and an overnight fast. I. Relationship to bile acid pool size and cholesterol saturation of bile in gallstone and control subjects. Gut 1975;16:1–11.Google ScholarPubMed
Angelin, B, Bjorkhem, I, Einarsson, K, Ewerth, S. Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum. J Clin Invest 1982;70:724–31.Google ScholarPubMed
Jaeschke, H, Gores, G J, Cederbaum, A I. Mechanisms of hepatotoxicity. Toxicol Sci 2002;65:166–76.CrossRefGoogle ScholarPubMed
Eloranta, J J, Kullak-Ublick, G A. Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism. Arch Biochem Biophys 2005;433:397–412.CrossRefGoogle ScholarPubMed
Karpen, S J. Exercising the nuclear option to treat cholestasis: CAR and PXR ligands. Hepatology 2005;42:266–9.CrossRefGoogle ScholarPubMed
Watkins, J B, Szczepanik, P, Gould, J B. Bile salt metabolism in the human premature infant. Preliminary observations of pool size and synthesis rate following prenatal administration of dexamethasone and phenobarbital. Gastroenterology 1975;69:706–13.Google ScholarPubMed
Suchy, F J, Balistreri, W F, Heubi, J E. Physiologic cholestasis: elevation of the primary serum bile acid concentrations in normal infants. Gastroenterology 1981;80(5 Pt 1):1037–41.Google Scholar
Rutherford, A E, Pratt, D S. Cholestasis and cholestatic syndromes. Curr Opin Gastroenterol 2006;22:209–14.CrossRefGoogle ScholarPubMed
Boyer, J L. Nuclear receptor ligands: rational and effective therapy for chronic cholestatic liver disease?Gastroenterology 2005;129:735–40.CrossRefGoogle ScholarPubMed
Osler, W H. Principles and practice of medicine. 4th ed. New York: Appleton, 1901.Google Scholar
Dunham, E C. Septicemia in the newborn. Am J Dis Child 1933; 45:229–53.Google Scholar
Rooney, J C, Hill, D J, Danks, D M. Jaundice associated with bacterial infection in the newborn. Am J Dis Child 1971;122:39–41.Google ScholarPubMed
Zimmerman, H J, Fang, M, Utili, R. Jaundice due to bacterial infection. Gastroenterology 1979;77:362–74.Google Scholar
Green, R M, Whiting, J F, Rosenbluth, A B. Interleukin-6 inhibits hepatocyte taurocholate uptake and sodium-potassium-adenosinetriphosphatase activity. Am J Physiol 1994;267(6 Pt 1): G1094–100.Google Scholar
Bolder, U, Tonnu, H T, Schteingart, C D. Hepatocyte transport of bile acids and organic anions in endotoxemic rats—impaired uptake and secretion. Gastroenterology 1997;112:214–25.CrossRefGoogle ScholarPubMed
Moseley, R H. Sepsis-associated cholestasis. Gastroenterology 1997;112:302–6.CrossRefGoogle ScholarPubMed
Moseley, R H. Sepsis and cholestasis. Clin Liver Dis 2004;8:83–94.CrossRefGoogle ScholarPubMed
Schwabe, R F, Seki, E, Brenner, D A. Toll-like receptor signaling in the liver. Gastroenterology 2006;130:1886–900.CrossRefGoogle ScholarPubMed
Baumann, H, Gauldie, J. The acute phase response. Immunol Today 1994;15:74–80.CrossRefGoogle ScholarPubMed
Baumann, H, Held, W A, Berger, F G. The acute phase response of mouse liver. Genetic analysis of the major acute phase reactants. J Biol Chem 1984;259:566–73.Google ScholarPubMed
Siewert, E, Dietrich, C G, Lammert, F. Interleukin-6 regulates hepatic transporters during acute-phase response. Biochem Biophys Res Commun 2004;322:232–8.CrossRefGoogle ScholarPubMed
Moshage, H. Cytokines and the hepatic acute phase response. J Pathol 1997;181:257–66.3.0.CO;2-U>CrossRefGoogle ScholarPubMed
Trauner, M, Wagner, M, Fickert, P, Zollner, G. Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis. J Clin Gastroenterol 2005;39(4 Suppl 2):S111–24.CrossRefGoogle Scholar
Bolder, U, Jeschke, M G, Landmann, L. Heat stress enhances recovery of hepatocyte bile acid and organic anion transporters in endotoxemic rats by multiple mechanisms. Cell Stress Chaperones 2006;11:89–100.CrossRefGoogle ScholarPubMed
Elferink, M G L, Olinga, P, Draaisma, A L. LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am J Physiol Gastrointest Liver Physiol 2004;287:G1008–16.CrossRefGoogle ScholarPubMed
Warskulat, U, Kubitz, R, Wettstein, M. Regulation of bile salt export pump mRNA levels by dexamethasone and osmolarity in cultured rat hepatocytes. Biol Chem 1999;380:1273–9.CrossRefGoogle ScholarPubMed
Kubitz, R, Wettstein, M, Warskulat, U, Haussinger, D. Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone. Gastroenterology 1999;116:401–10.CrossRefGoogle ScholarPubMed
Navarro, V J, Senior, J R. Drug-related hepatotoxicity. N Engl J Med 2006;354:731–9.CrossRefGoogle ScholarPubMed
Bonioli, E, Bellini, C, Toma, P. Pseudolithiasis and intractable hiccups in a boy receiving ceftriaxone. N Engl J Med 1994;331:1532.CrossRefGoogle Scholar
Kearns, G L, Abdel-Rahman, S M, Alander, S W. Developmental pharmacology—drug disposition, action, and therapy in infants and children. N Engl J Med 2003;349:1157–67.CrossRefGoogle Scholar
Abernathy, C O, Utili, R, Zimmerman, H J. Immaturity of the biliary excretory system predisposes neonates to intrahepatic cholestasis. Med Hypotheses 1979;5:641–7.CrossRefGoogle ScholarPubMed
Sondheimer, J M, Asturias, E, Cadnapaphornchai, M. Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 1998;27:131–7.CrossRefGoogle ScholarPubMed
Buchman, A L, Iyer, K, Fryer, J. Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation. Hepatology 2006;43:9–19.CrossRefGoogle ScholarPubMed
Teitelbaum, D H, Han-Markey, T, Drongowski, R A. Use of cholecystokinin to prevent the development of parenteral nutrition-associated cholestasis. JPEN J Parenter Enteral Nutr 1997;21:100–3.CrossRefGoogle ScholarPubMed
Colomb, V, Jobert-Giraud, A, Lacaille, F. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr 2000;24:345–50.CrossRefGoogle ScholarPubMed
Cavicchi, M, Beau, P, Crenn, P. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 2000;132:525–32.CrossRefGoogle ScholarPubMed
Houten, S M, Watanabe, M, Auwerx, J. Endocrine functions of bile acids. EMBO J 2006;25:1419–25.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Mechanisms of Bile Formation and Cholestasis
    • By Saul J. Karpen, M.D., Ph.D., Associate Professor of Pediatrics and Molecular and Cellular Biology, Faculty, Transitional Biology and Molecular Medicine Program, Department of Pediatrics, Baylor College of Medicine, Houston, Texas; Director, Texas Children's Liver Center, Department of Pediatric Gastroenterology, Hepatology, and Nutrition, Texas Children's Hospital, Houston, Texas
  • Edited by Frederick J. Suchy, Mount Sinai School of Medicine, New York, Ronald J. Sokol, University of Colorado, Denver, William F. Balistreri, University of Cincinnati
  • Book: Liver Disease in Children
  • Online publication: 18 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547409.005
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Mechanisms of Bile Formation and Cholestasis
    • By Saul J. Karpen, M.D., Ph.D., Associate Professor of Pediatrics and Molecular and Cellular Biology, Faculty, Transitional Biology and Molecular Medicine Program, Department of Pediatrics, Baylor College of Medicine, Houston, Texas; Director, Texas Children's Liver Center, Department of Pediatric Gastroenterology, Hepatology, and Nutrition, Texas Children's Hospital, Houston, Texas
  • Edited by Frederick J. Suchy, Mount Sinai School of Medicine, New York, Ronald J. Sokol, University of Colorado, Denver, William F. Balistreri, University of Cincinnati
  • Book: Liver Disease in Children
  • Online publication: 18 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547409.005
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Mechanisms of Bile Formation and Cholestasis
    • By Saul J. Karpen, M.D., Ph.D., Associate Professor of Pediatrics and Molecular and Cellular Biology, Faculty, Transitional Biology and Molecular Medicine Program, Department of Pediatrics, Baylor College of Medicine, Houston, Texas; Director, Texas Children's Liver Center, Department of Pediatric Gastroenterology, Hepatology, and Nutrition, Texas Children's Hospital, Houston, Texas
  • Edited by Frederick J. Suchy, Mount Sinai School of Medicine, New York, Ronald J. Sokol, University of Colorado, Denver, William F. Balistreri, University of Cincinnati
  • Book: Liver Disease in Children
  • Online publication: 18 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547409.005
Available formats
×